title: [Prescription and monitoring of anticoagulant therapies].
authors: Centre de référence des maladies vasculaires rares, hôpital européen Georges-Pompidou, AP-HP, Paris, France. michael.frank@egp.aphp.fr
authors: Michael
authors: M
authors: Frank
authors: Anne-Marie
authors: AM
authors: Fischer
mesh_terms: D015110:4-Hydroxycoumarins / Q000009:adverse effects / Q000627:therapeutic use; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007192:Indenes / Q000009:adverse effects / Q000627:therapeutic use; D008991:Monitoring, Physiologic / Q000379:methods*; D010818:Practice Patterns, Physicians' / Q000592:standards; D013917:Thrombin / Q000037:antagonists & inhibitors; D014812:Vitamin K / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000627:therapeutic use
chemical_list: D015110:4-Hydroxycoumarins; D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D007192:Indenes; C011664:antivitamins K; D014812:Vitamin K; D013917:Thrombin; D001241:Aspirin